{
"procedureNumber": "EMEA/H/C/000481/II/0146",
"productName": "Humira",
"productNumber": "1001",
"procedureType": "TYPE_II",
"activeSubstance": "adalimumab",
"additionalMonitoring": true,
"article58": true,
"atc": "L04AB04",
"biosimilar": true,
"conditionalApproval": true,
"exceptionalCircumstances": true,
"generic": true,
"legalAction": true,
"mah": "AbbVie Ltd",
"orphan": true,
"paediatric": true,
"productStatus": "PENDING",
"smallMediumEnterprise": true,
"plannedChmpOpinionDate": "2016-08-08T00:00:00",
"procedureStartDate": "2016-08-01T00:00:00"}
